Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.3M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$16.5M |
| 3 |
ICL Group
ICL
|
+$11.3M |
| 4 |
Liberty Media Series C
FWONK
|
+$9.18M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$6.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.7M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$23.5M |
| 3 |
ExxonMobil
XOM
|
+$11.1M |
| 4 |
IBM
IBM
|
+$8.88M |
| 5 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.81% |
| 2 | Technology | 13.76% |
| 3 | Energy | 11.48% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Omnicell
OMCL
$1.72B
| $1.11M | ﹤0.01% |
40,500
| – | – |
|
1602
Boise Cascade
BCC
$2.94B
| $1.11M | ﹤0.01% |
36,700
-600
| -2% | -$17.6K |
|
|
SFR
1603
DELISTED
Starwood Waypoint Homes
SFR
| $1.11M | ﹤0.01% |
42,540
| – | – |
|
1604
Axos Financial
AX
$5.72B
| $1.1M | ﹤0.01% |
60,800
| – | – |
|
|
CRAY
1605
DELISTED
Cray, Inc.
CRAY
| $1.1M | ﹤0.01% |
42,100
-700
| -2% | -$19.4K |
|
|
KAMN
1606
DELISTED
Kaman Corp
KAMN
| $1.1M | ﹤0.01% |
28,100
| – | – |
|
|
FNFV
1607
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $1.1M | ﹤0.01% |
+105,083
| New | +$1.25M |
|
|
PLKI
1608
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $1.09M | ﹤0.01% |
27,000
-700
| -3% | -$28.5K |
|
|
STL
1609
DELISTED
Sterling Bancorp
STL
| $1.09M | ﹤0.01% |
85,452
-1,600
| -2% | -$19.8K |
|
|
VRTU
1610
DELISTED
Virtusa Corporation
VRTU
| $1.09M | ﹤0.01% |
30,700
| – | – |
|
|
MDC
1611
DELISTED
M.D.C. Holdings, Inc.
MDC
| $1.09M | ﹤0.01% |
59,859
-1,389
| -2% | -$28.1K |
|
1612
Albany International
AIN
$1.82B
| $1.09M | ﹤0.01% |
32,000
| – | – |
|
|
SWIR
1613
DELISTED
Sierra Wireless
SWIR
| $1.09M | ﹤0.01% |
40,500
| – | – |
|
1614
Scansource
SCSC
$1.06B
| $1.09M | ﹤0.01% |
31,400
| – | – |
|
|
CCMP
1615
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.09M | ﹤0.01% |
26,200
-700
| -3% | -$29.8K |
|
|
CLVS
1616
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.08M | ﹤0.01% |
23,900
-400
| -2% | -$16.7K |
|
1617
Universal Corp
UVV
$1.12B
| $1.08M | ﹤0.01% |
24,400
-600
| -2% | -$30.9K |
|
1618
AAR Corp
AIR
$5.77B
| $1.08M | ﹤0.01% |
44,800
-900
| -2% | -$24.4K |
|
1619
WD-40
WDFC
$3.09B
| $1.08M | ﹤0.01% |
15,900
-500
| -3% | -$34.7K |
|
|
SEM
1620
DELISTED
Select Medical
SEM
| $1.08M | ﹤0.01% |
166,298
-12,249
| -7% | -$94.6K |
|
|
ABMD
1621
DELISTED
Abiomed Inc
ABMD
| $1.08M | ﹤0.01% |
43,400
| – | – |
|
|
EDE
1622
DELISTED
Empire District Electric
EDE
| $1.07M | ﹤0.01% |
44,400
-800
| -2% | -$20.1K |
|
|
PINC
1623
DELISTED
Premier
PINC
| $1.07M | ﹤0.01% |
32,600
+5,300
| +19% | +$159K |
|
1624
Piper Sandler
PIPR
$5.54B
| $1.07M | ﹤0.01% |
82,000
+16,400
| +25% | +$219K |
|
1625
Rogers Corp
ROG
$2.46B
| $1.07M | ﹤0.01% |
19,500
| – | – |
|
Similar funds
Swiss National Bank's Q3 2014 Portfolio in Review
As of Q3 2014, Swiss National Bank held 2,547 positions worth $26.1B, down 3.5% from $27B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 1.3%. Swiss National Bank opened 15 new positions and exited 18, leaving the 2,547-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
- Swiss National Bank's largest Q3 2014 buy was Weatherford International plc: 735,946 shares worth $15.3M.
- Swiss National Bank added most to Allergan plc in Q3 2014, an estimated $18.3M increase.
- Swiss National Bank's biggest Q3 2014 reduction was Apple, cutting an estimated $23.7M.
- Swiss National Bank fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $23.5M.
- Swiss National Bank's ten largest holdings make up 14% of its $26.1B portfolio in Q3 2014.
- Swiss National Bank opened 15 new positions and closed 18 in Q3 2014.
- Swiss National Bank's portfolio value fell 3.5% quarter-over-quarter to $26.1B.
Based on Swiss National Bank's 13F filing for Q3 2014, filed 4 Nov 2014.